We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

120 hedge funds and large institutions have $58.1M invested in Sanofi Contingent Value Rights in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $39.6M → $58.1M (+$18.5M)

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

3% more funds holding

Funds holding: 116 → 120 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

57% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 28

Holders
120
Holders Change
+4
Holders Change %
+3.45%
% of All Funds
3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
12
Reduced
28
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$3.5M
2
PC
PointState Capital
New York
+$2.47M
3
FCM
Farallon Capital Management
California
+$1.35M
4
TAM
TFG Asset Management
Cayman Islands
+$904K
5
HCM
Highbridge Capital Management
New York
+$750K

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$1.97M
2
WA
Whitebox Advisors
Minnesota
-$1.68M
3
NGA
New Generation Advisors
Massachusetts
-$1.55M
4
BHMP
Bardin Hill Management Partners
New York
-$994K
5
Millennium Management
Millennium Management
New York
-$254K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teton Advisors
New York
$152K – – –
PAAMCP
27
Pacific Alternative Asset Management Company (PAAMCO)
California
$100K +$89K +262,900 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$78K +$61K +180,272 +712%
YCM
29
Yakira Capital Management
Connecticut
$59K – – –
BCM
30
Basso Capital Management
Connecticut
$57K -$8.46K -25,000 -14%
First Eagle Investment Management
31
First Eagle Investment Management
New York
$56K – – –
CI
32
Cowen Inc
New York
$54K +$48.3K +142,624 New
Bank of America
33
Bank of America
North Carolina
$47K +$44 +130 +0.1%
UBS Group
34
UBS Group
Switzerland
$41K -$6.96K -20,577 -16%
EEG
35
E.E. Geduld
$38K -$8.46K -25,000 -20%
IRF
36
IBM Retirement Fund
New York
$26K – – –
GI
37
GAMCO Investors
Connecticut
$25K – – –
JP Morgan Chase
38
JP Morgan Chase
New York
$23K – – –
Wells Fargo
39
Wells Fargo
California
$22K -$438 -1,295 -2%
Citadel Advisors
40
Citadel Advisors
Florida
$21K -$6.74K -19,919 -26%
Korea Investment Corp
41
Korea Investment Corp
South Korea
$19K – – –
OCM
42
Osterweis Capital Management
California
$19K – – –
ZIG
43
Zuckerman Investment Group
Illinois
$17K -$7 -20 -0%
Commonwealth Equity Services
44
Commonwealth Equity Services
Massachusetts
$16K +$9 +28 +0.1%
DBG
45
De Burlo Group
Massachusetts
$15K – – –
CHAM
46
Clear Harbor Asset Management
Connecticut
$13K – – –
FHA
47
Flagship Harbor Advisors
Massachusetts
$13K +$9.44K +27,891 New
WHI
48
William Harris Investors
Illinois
$12K – – –
Morgan Stanley
49
Morgan Stanley
New York
$11K -$238 -704 -2%
SDWMA
50
Schneider Downs Wealth Management Advisors
Pennsylvania
$10K – – –
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q4 2016 in Review

120 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2016, worth a combined $58.1M — up 47% from $39.6M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GCVRZ positions and 13 closed out — a net gain of 4 holders — while 12 added to existing stakes and 28 trimmed.

The largest buyer was Stonehill Capital Management, adding an estimated $3.5M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $1.97M.

  • 120 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2016, up from 116 in Q3 2016.
  • Funds reported $58.1M of Sanofi Contingent Value Rights stock for Q4 2016, up 47% quarter-over-quarter.
  • 17 funds opened new Sanofi Contingent Value Rights positions in Q4 2016 and 13 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2016 was Stonehill Capital Management, an estimated $3.5M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2016 was TPG Group Holdings (SBS) Advisors, an estimated $1.97M sold.

Based on aggregated 13F filings for Q4 2016.